Skip to content

908 Devices MASS Deferred revenue, net of current portion

Deferred revenue, net of current portion at other companies

Idexx Laboratories logo
Idexx LaboratoriesIDXX
$32.31M+20.5%
Ametek logo
AmetekAME
$41.8M+5.3%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
SPX Technologies logo
SPX TechnologiesSPXC

Other financials

Income statement

See full
Revenue$13.4M+13.6%
Gross profit$6.9M+24.2%
Operating income-$12.9M-16.9%
Net income-$12.0M-127%
EPS (diluted)-$0.32-126%

Balance sheet

See full
Cash & equivalents$67.6M-14.7%
Total debt$4.5M+18.6%
Total equity$134.2M-15.8%
Total assets$186.7M-4.8%

Cash flow

See full
Operating cash flow$1.2M+108%
CapEx$40.0K-74.8%
Free cash flow$1.2M+108%

Valuation

See full
Market cap$339.57M+29.0%
Enterprise value$276.47M+47.2%
P/S5.9×+0.8×

Profitability

See full
Gross margin51.5%+1.3pp
Operating margin-76.8%-19.6pp
Net margin-62.4%+323pp
FCF margin-16.7%-7.2pp

Returns & leverage

See full
Return on equity-24.6%-149pp
Debt / equity0.0×
Current ratio3.6×-4.0×

Where this comes from

Reported directly by 908 Devices in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.

The official record: 908 Devices’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about 908 Devices's deferred revenue, net of current portion.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is 908 Devices's deferred revenue, net of current portion?
908 Devices (MASS) reported deferred revenue, net of current portion of $9.07M in Q1 2026.
How has 908 Devices's deferred revenue, net of current portion changed year-over-year?
908 Devices's deferred revenue, net of current portion decreased by 5.0% year-over-year, from $9.55M to $9.07M.
What is the long-term trend for 908 Devices's deferred revenue, net of current portion?
Over 5 years (2020 to 2025), 908 Devices's deferred revenue, net of current portion has grown at a -0.6% compound annual growth rate (CAGR), from $8.59M to $8.33M.